Guardant Health, Inc.
GH
$85.49
$1.471.75%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 281.27M | 265.20M | 232.09M | 203.47M | 201.81M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 281.27M | 265.20M | 232.09M | 203.47M | 201.81M |
| Cost of Revenue | 99.49M | 93.59M | 81.21M | 74.72M | 77.59M |
| Gross Profit | 181.77M | 171.61M | 150.88M | 128.75M | 124.22M |
| SG&A Expenses | 204.20M | 180.53M | 169.62M | 150.78M | 156.39M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 401.96M | 364.07M | 338.27M | 314.02M | 327.53M |
| Operating Income | -120.69M | -98.87M | -106.18M | -110.55M | -125.72M |
| Income Before Tax | -130.22M | -92.59M | -99.86M | -94.87M | -110.29M |
| Income Tax Expenses | -1.73M | 136.00K | 38.00K | 290.00K | 716.00K |
| Earnings from Continuing Operations | -128.49M | -92.73M | -99.90M | -95.16M | -111.01M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -128.49M | -92.73M | -99.90M | -95.16M | -111.01M |
| EBIT | -120.69M | -98.87M | -106.18M | -110.55M | -125.72M |
| EBITDA | -110.64M | -89.47M | -96.14M | -100.32M | -115.26M |
| EPS Basic | -1.00 | -0.74 | -0.80 | -0.77 | -0.90 |
| Normalized Basic EPS | -0.57 | -0.46 | -0.50 | -0.45 | -0.57 |
| EPS Diluted | -1.00 | -0.74 | -0.80 | -0.77 | -0.90 |
| Normalized Diluted EPS | -0.57 | -0.46 | -0.50 | -0.45 | -0.57 |
| Average Basic Shares Outstanding | 128.66M | 124.81M | 124.11M | 123.87M | 123.75M |
| Average Diluted Shares Outstanding | 128.66M | 124.81M | 124.11M | 123.87M | 123.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |